Logo
Search
Login
Sign Up
Logo
Oliver Buchannon
Dr. Susannah F. Vanderpool

Neonatal & Pediatric Clinical Pharmacist

US 2026 measles cases already surpass 2025 total

Aug 4, 2026

•

3 min read

US 2026 measles cases already surpass 2025 total

High-risk medication errors accounted for 21% of all reported errors in a pediatric unit

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Bicillin shortage extended to December 2027

Jul 28, 2026

•

3 min read

Bicillin shortage extended to December 2027

Empiric cephalosporins are reserved for meningitis, AKI, or gentamicin nephrotoxicity

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Dexmedetomidine delays full oral feeding after cooling

Jul 21, 2026

•

3 min read

Dexmedetomidine delays full oral feeding after cooling

Tralokinumab was well tolerated for up to 172 weeks in a Phase 2 pediatric eczema trial

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
1.8% vs 3%: no acetaminophen autism link in 1.5M cohort

Jul 14, 2026

•

3 min read

1.8% vs 3%: no acetaminophen autism link in 1.5M cohort

Accidental diphenhydramine overdoses linked to three pediatric deaths this year

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Neuroinflammatory syndromes in 4 children on dupilumab

Jul 7, 2026

•

3 min read

Neuroinflammatory syndromes in 4 children on dupilumab

FDA approves Afrezza inhaled mealtime insulin for children 6 and older with diabetes

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Why the hepatitis B birth dose still matters

Jun 30, 2026

•

3 min read

Why the hepatitis B birth dose still matters

FDA clears Dexcom Stelo, the first OTC continuous glucose monitor for children 2 and older

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Pediatric antibiotic dispensing rebounded to pre-pandemic levels by 2024

Jun 23, 2026

•

3 min read

Pediatric antibiotic dispensing rebounded to pre-pandemic levels by 2024

Post-pandemic dispensing tracked closely with confirmed influenza and RSV cases in children

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Maternal RSV vaccine 67.6% effective vs infant RSV hospitalization

Jun 16, 2026

•

3 min read

Maternal RSV vaccine 67.6% effective vs infant RSV hospitalization

Neonates' high total body water raises the volume of distribution for water-soluble drugs like gentamicin

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
GLP-1 prescriptions in adolescents up 600% with long-term effects unknown

Jun 9, 2026

•

3 min read

GLP-1 prescriptions in adolescents up 600% with long-term effects unknown

Oral sucrose 0.1–0.5 mL given 1–2 minutes before mildly painful neonatal procedures is first-line pre-emptive analgesia; limit to 10 doses daily.

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Fewer than 23% of kids with SCD get >300 days/yr Rx

Jun 2, 2026

•

3 min read

Fewer than 23% of kids with SCD get >300 days/yr Rx

Ceftriaxone-associated kernicterus has never been reported in a neonate

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Dexmedetomidine decreases opioid requirements and facilitates ventilator weaning in neonates

May 26, 2026

•

3 min read

Dexmedetomidine decreases opioid requirements and facilitates ventilator weaning in neonates

IV paracetamol (acetaminophen) can cut 48-hour morphine exposure by 79% after cardiac surgery

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Bayesian vancomycin dosing hits target in 100% of neonates

May 19, 2026

•

3 min read

Bayesian vancomycin dosing hits target in 100% of neonates

A single sample ≥ 5 hours after the first dose accurately predicts AUC for neonatal vancomycin

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Symptom-based opioid dosing cut NOWS discharge time by 2.3 days

May 12, 2026

•

8 min read

Symptom-based opioid dosing cut NOWS discharge time by 2.3 days

FDA expands Stelara approval to children 2+ with moderately to severely active Crohn's disease

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Expectant PDA management cut mortality from 9.6% to 4.1% in preemies

May 5, 2026

•

8 min read

Expectant PDA management cut mortality from 9.6% to 4.1% in preemies

Vancomycin and gentamicin are the antibiotics most commonly implicated in neonatal AKI

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
2026 Surviving Sepsis pediatric guideline: what changed

Apr 28, 2026

•

8 min read

2026 Surviving Sepsis pediatric guideline: what changed

Ceftriaxone displaces bilirubin from albumin binding sites and can raise free bilirubin in neonates

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
2026 ADA Standards expand SGLT2i options for pediatric type 2 diabetes

Apr 21, 2026

•

8 min read

2026 ADA Standards expand SGLT2i options for pediatric type 2 diabetes

Nearly 25% of children in LMICs experience Shigella diarrhea requiring medical attention by age 2.

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Pediatric empyema: 2026 IDSA/PIDS CAP guideline favors fibrinolytics over VATS

Apr 14, 2026

•

1 min read

Pediatric empyema: 2026 IDSA/PIDS CAP guideline favors fibrinolytics over VATS

FDA alerts clinicians to undeclared DMAA, DMHA, and phenibut in Addall supplements

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
New PALS diastolic BP targets during pediatric CPR

Apr 7, 2026

•

1 min read

New PALS diastolic BP targets during pediatric CPR

Cefepime is preferred over ceftazidime when a cephalosporin is needed for neonatal sepsis or meningitis

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Surfactant didn't shorten ventilation in infant bronchiolitis (BESS trial)

Mar 31, 2026

•

1 min read

Surfactant didn't shorten ventilation in infant bronchiolitis (BESS trial)

~89,000 bottles of Children's Ibuprofen recalled after reports of foreign particles

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Tirzepatide cuts HbA1c by 2.23% in youth-onset type 2 diabetes

Mar 24, 2026

•

1 min read

Tirzepatide cuts HbA1c by 2.23% in youth-onset type 2 diabetes

Federal court restores pre-January 2026 pediatric vaccine schedule

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Clinical Insights - Mar 17, 2026

Mar 17, 2026

•

4 min read

Clinical Insights - Mar 17, 2026

Nearly 20,000 U.S. emergency department visits occur each year for oral prescription medication ingestions in children younger than 6 years. Clonidine and buprenorphine account for the highest hospitalization estimates.

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Clinical Insights - Mar 10, 2026

Mar 10, 2026

•

4 min read

Clinical Insights - Mar 10, 2026

A 10-day hydrocortisone taper given at 14-28 days of life in ventilated preterm infants did not significantly impact functional outcomes at early school age compared with placebo.

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Clinical Insights - Mar 3, 2026

Mar 3, 2026

•

4 min read

Clinical Insights - Mar 3, 2026

Six weeks of once-daily intranasal saline resolved symptoms in 29.5% of children 3-12 years old, with cumulative resolution near 50% after 12 weeks. Adding mometasone after nonresponse did not improve outcomes.

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Clinical Insights - Feb 24, 2026

Feb 24, 2026

•

4 min read

Clinical Insights - Feb 24, 2026

In 44 pediatric cardiac patients 0-24 months of age (median 2.1 months), the median clopidogrel dose associated with therapeutic P2Y12 reaction unit (PRU) values was 0.22 mg/kg/day (IQR 0.19-0.34). This conflicts with the fixed 0.2 mg/kg/day recommended by the PICOLO trial.

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Clinical Insights - Feb 17, 2026

Feb 17, 2026

•

4 min read

Clinical Insights - Feb 17, 2026

Explainable machine learning models achieved higher simulated therapeutic alignment than standard weight-based dosing in young children, though findings remain exploratory.

Dr. Susannah F. Vanderpool
Dr. Susannah F. Vanderpool
Load more

Pediatric Pearls

Clinical insights for neonatal & pediatric care.

© 2026 Pediatric Pearls.
beehiivPowered by beehiiv